A modified tetracycline compound called DDOX demonstrates remarkable multi-target effects against Parkinson’s disease pathology. The non-antibiotic derivative prevents cellular uptake of toxic protein fibrils while addressing multiple aspects of disease progression.
Nvidia has achieved what no company in history has accomplished – a $5 trillion market capitalization. This milestone underscores the chipmaker’s central role in powering the global AI revolution, but also raises questions about sustainability amid growing competition and geopolitical tensions.
Cancer treatment is undergoing a microscopic revolution as nanobots deliver drugs with unprecedented precision. From DNA origami robots to biohybrid sperm carriers, these tiny machines are changing oncology.
A former OpenAI insider warns the company has failed its users as mental health emergencies linked to AI chatbots escalate. The crisis reveals fundamental flaws in how tech giants approach AI safety.
Researchers have developed a non-damaging laser therapy that activates the retina’s natural healing mechanisms. The breakthrough could transform treatment for degenerative eye diseases by stimulating protective cellular responses without causing tissue damage.
While AI technology advances rapidly, most enterprise implementations fail to deliver value. The real challenge isn’t technical capability but organizational structure and leadership alignment. Companies that master the operating model will dominate the next decade.
When Microsoft considered investing $1 billion in OpenAI in 2019, Bill Gates warned they’d “burn this billion dollars.” Five years later, that gamble has transformed into a $135 billion stake. The story behind tech’s most controversial partnership.
Scientists have discovered that gut bacteria only activate their CRISPR-Cas immune systems when oxygen levels drop. This explains why decades of lab research missed this crucial defense mechanism operating in our intestines.
Machine learning models predicting cognitive abilities may be fundamentally flawed, according to new research. The study reveals how confound leakage creates artificially inflated accuracy that could mislead clinical diagnoses and research.
The UK AI Security Institute has partnered with security firms to launch an open source framework targeting LLM vulnerabilities in AI agents. The backbone breaker benchmark uses threat snapshots to identify security weaknesses before attackers can exploit them.
